Mia's Feed
Medical News & Research

How Brain Stimulation Can Reduce Symptoms of Parkinson's Disease

How Brain Stimulation Can Reduce Symptoms of Parkinson's Disease

Share this article

New research explores how targeted brain stimulation, including optogenetics, can activate motor pathways outside traditional regions to alleviate symptoms of Parkinson's disease and improve mobility.

2 min read

Parkinson's disease progressively impairs mobility, often leaving patients unable to walk in advanced stages. A promising therapeutic approach for these individuals is deep brain stimulation (DBS), often referred to as a brain pacemaker. Recent research by scientists at Ruhr University Bochum and Philipps-Universität Marburg in Germany has explored how stimulating specific brain regions can improve ambulatory capacity and enhance quality of life for Parkinson's patients.

Using a cutting-edge technique called optogenetics, which involves activating or inhibiting nerve cells with light, researchers investigated the potential of stimulating the inferior colliculus—a brain area primarily known for processing auditory information—to promote mobility. Their study, published in Scientific Reports, suggests that such stimulation activates the mesencephalic locomotor region (MLR), which directly influences movement.

Deep brain stimulation typically targets the basal ganglia, such as the subthalamic nucleus, but the new findings highlight alternative pathways outside these regions. Notably, the inferior colliculus is not affected by Parkinson's, yet its stimulation seems to activate motor pathways involved in movement control. This research builds on previous studies in rats, where stimulation of the inferior colliculus was shown to overcome mobility restrictions.

The team employed sophisticated optogenetic methods, which involve genetically modifying nerve cells to produce light-sensitive proteins. Miniature optical fibers deliver precise light pulses to specific brain regions, allowing targeted activation. During experiments, electrophysiological recordings demonstrated that stimulation of the inferior colliculus increased activity in the MLR, with some nerve cells being inhibited to fine-tune responses.

This approach offers valuable insights into new therapeutic avenues. By revealing how circuits outside the traditional basal ganglia pathways can influence motor function, researchers aim to develop innovative strategies to manage Parkinson's symptoms more effectively. While clinical applications are still in development, this foundational research marks an important step toward more targeted and refined treatments.

Source: https://medicalxpress.com/news/2025-05-brain-alleviates-symptoms-parkinson-disease.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Impact of Parental Substance Use Disorder on Millions of U.S. Children

Nearly 19 million children in the U.S. live with parents suffering from substance use disorder, leading to significant mental health and behavioral risks. Recent studies highlight the urgent need for better screening and intervention strategies.

No Evidence Supports Work Requirements for Medicaid Recipients to Increase Employment

Studies show that work requirements for Medicaid do not increase employment and often restrict access to vital health services, failing to meet policy goals.

Study Links Oral Contraceptives to Increased Risk of Cryptogenic Stroke in Young Women

Research shows that combined oral contraceptives triple the risk of cryptogenic stroke in young women, highlighting the importance of personalized medical assessments.

Court Mandates Continuation of Hormone Therapy for Transgender Inmates

A federal court has ruled that transgender inmates must continue receiving hormone therapy and gender-affirming care, challenging restrictions imposed by previous policies. The decision emphasizes inmates’ health rights and the importance of ongoing medical treatment for gender dysphoria.